ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/31/2025
Back to search
Official data from USPTO
XUPREMAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
01/01/2026
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
03/14/2023
Registration date
12/10/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/10/2024
Last transaction
01/01/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/15/2023
First use in commerce
05/15/2023
Drawing code
4
Owner type
99
Owner location
SHANGHAI, CN
Examiner
CHADAB,SETH WILLIG
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SHANGHAI AILUX BIOTECHNOLOGY CO., LTD.
Shenzhen Jingtai Technology Co., Ltd.
Representatives
Alex Patel Patel IP, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biochemical research and development; Biomedical research services; Cloud computing featuring software for use antibody developmentmedical research and drug discovery; Cloud storage services for electronic data; Conducting early evaluations in the field of new pharmaceuticals; Consulting services for others in the field of designplanningimplementation project management of clinical trialsantibody iptimization and macromolecule drug discovery; Development of pharmaceutical preparations and medicines; DNA sequencing technology research; Drug discovery services; Medical laboratory services; Medical research; Pharmaceutical drug development services; Pharmaceutical product evaluation; Product quality testing; Rental of laboratory apparatus and instruments; Research and development of new products for others; Research and development services in the field of antibodies; Research in the field of artificial intelligence; Research in the field of chemistry; Research in the field of manufacturing machinery; Research on the subject of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
21 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/27/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/27/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/27/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/10/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/18/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/18/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/08/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/08/2024
IUAF
USE AMENDMENT FILED
08/05/2024
EISU
TEAS STATEMENT OF USE RECEIVED
08/05/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/19/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2024
PUBO
PUBLISHED FOR OPPOSITION
01/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2023
DOCK
ASSIGNED TO EXAMINER
12/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/04/2023
NWAP
NEW APPLICATION ENTERED
03/17/2023
Continuous trademark protection
Get notified about every new filing that threatens XUPREMAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.